Kelley Drye & Warren LLP has announced that Siobhan McCleary has joined the firm as Partner in the Corporate Department, specializing in the area of private equity. Ms. McCleary will practice in the firm's New York office.
Ms. McCleary's practice focuses on the representation of private equity funds and their portfolio companies, including venture capital financings and merger and acquisition transactions. Ms. McCleary also has extensive experience representing start-up and early stage biotechnology, pharmaceutical and technology companies in all aspects of the business cycle, from formation through multiple financings to IPO, as well as corporate counseling for day-to-day operations. In addition, Ms. McCleary has represented biotechnology and pharmaceutical companies and technology companies in connection with the licensing of intellectual property rights and the licensing, development and distribution of software respectively.
For the first four years of her legal career, Ms. McCleary was an associate at O'Sullivan, Graev & Karabell LLP, where she represented private equity funds in connection with venture capital financings and merger and acquisition transactions.
The addition of Ms. McCleary will bolster the growth of the firm's Private Equity Practice Group. The practice has a long-standing representation of venture capital and private equity funds, large pension plans and institutional investors including Credit Suisse Private Equity, Thomas Weisel Capital Partners (and its manager, Tailwind Capital Partners) and ProQuest Investments in a multitude of portfolio company investments and acquisitions. Kelley Drye has in-depth involvement with numerous start-up and developmental stage companies due to the group's venture capital and private equity history and current-market experience.